表紙:粒子線治療の世界市場規模:タイプ、製品・サービス、がんタイプ、地域別の予測(2022年~2028年)
市場調査レポート
商品コード
1090012

粒子線治療の世界市場規模:タイプ、製品・サービス、がんタイプ、地域別の予測(2022年~2028年)

Global Particle Therapy Market Size study, By Type, By Product & Service, By Cancer Type, and Regional Forecasts 2022-2028

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
粒子線治療の世界市場規模:タイプ、製品・サービス、がんタイプ、地域別の予測(2022年~2028年)
出版日: 2022年06月07日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の粒子線治療の市場規模は、2021年に約6億2,569万米ドルとなり、2022年~2028年の間の予測期間中に8.2%以上の好調な成長率で成長すると予測されています。

がんの発症率の上昇、臨床試験における粒子線治療の採用拡大、新しい技術の出現、世界の粒子線治療センターの増加などが、市場成長の主要な要因となっています。しかし、放射線被曝リスクの高まりや医療施設のインフラ的な課題が、2022年~2028年の間の予測期間中の市場成長を妨げる見通しです。また、新興市場における粒子線治療の需要増加や医療費増大が、予測期間中の市場需要を促進すると予測されます。

当レポートでは、世界の粒子線治療市場について調査分析し、市場動向、競合情勢、セグメント別・地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の粒子線治療市場の定義と範囲

第3章 世界の粒子線治療市場力学

  • 粒子線治療市場影響分析(2020年~2028年)

第4章 世界の粒子線治療市場業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価:COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界の粒子線治療市場:タイプ別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析:タイプ別
  • 市場推計と予測:タイプ別
    • 陽子線治療
    • 重イオン療法

第7章 世界の粒子線治療市場:製品・サービス別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析:製品・サービス別
  • 市場推計と予測:製品・サービス別(2018年~2028年)
  • サブセグメント分析
    • 製品
    • サービス

第8章 世界の粒子線治療市場:がんタイプ別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析:がんタイプ別
  • 市場推計と予測:がんタイプ別(2018年~2028年)
  • サブセグメント分析
    • 小児がん
    • 前立腺がん
    • 肺がん
    • 乳がん
    • 頭頸部がん
    • その他のがん

第9章 世界の粒子線治療市場:地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • 主要な市場戦略
  • 企業プロファイル
    • Varian Medical Systems, Inc.
    • Hitachi, Ltd.
    • Sumitomo Heavy Industries, Ltd.
    • Danfysik A/S
    • Hitachi, Ltd
    • Ion Beam Applications Sa(IBA)
    • Mevion Medical Systems, Inc.
    • Optivus Proton Therapy, Inc.
    • ProTom International, Inc.
    • Provision Healthcare, LLC
    • Sumitomo Heavy Industries, Ltd.

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Particle Therapy Market, report scope
  • TABLE 2. Global Particle Therapy Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Particle Therapy Market estimates & forecasts by Type 2018-2028 (USD Million)
  • TABLE 4. Global Particle Therapy Market estimates & forecasts by Product & Service 2018-2028 (USD Million)
  • TABLE 5. Global Particle Therapy Market estimates & forecasts by Cancer Type 2018-2028 (USD Million)
  • TABLE 6. Global Particle Therapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Particle Therapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Particle Therapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Particle Therapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Particle Therapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Particle Therapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Particle Therapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Particle Therapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Particle Therapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Particle Therapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. U.S. Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. Canada Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 20. Canada Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. Canada Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. UK Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 23. UK Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. UK Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. Germany Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 26. Germany Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. Germany Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. RoE Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 29. RoE Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. RoE Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. China Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 32. China Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. China Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. India Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 35. India Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. India Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. Japan Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 38. Japan Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. Japan Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. Brazil Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 44. Brazil Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Brazil Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Mexico Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 47. Mexico Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. Mexico Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. RoLA Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 50. RoLA Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. RoLA Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. Row Particle Therapy Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 53. Row Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. Row Particle Therapy Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. List of secondary sources, used in the study of global Particle Therapy Market
  • TABLE 56. List of primary sources, used in the study of global Particle Therapy Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Particle Therapy Market, research methodology
  • FIG 2. Global Particle Therapy Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Particle Therapy Market, key trends 2021
  • FIG 5. Global Particle Therapy Market, growth prospects 2022-2028
  • FIG 6. Global Particle Therapy Market, porters 5 force model
  • FIG 7. Global Particle Therapy Market, pest analysis
  • FIG 8. Global Particle Therapy Market, value chain analysis
  • FIG 9. Global Particle Therapy Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Particle Therapy Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Particle Therapy Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Particle Therapy Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Particle Therapy Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Particle Therapy Market, regional snapshot 2018 & 2028
  • FIG 15. North America Particle Therapy Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Particle Therapy Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Particle Therapy market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Particle Therapy Market 2018 & 2028 (USD Million)
  • FIG 19. Global Particle Therapy Market, company market share analysis (2021)
目次

Global Particle Therapy Market is valued at approximately USD 625.69 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.2% over the forecast period 2022-2028. Particle therapy is a type of external beam radiotherapy that uses beams of energetic protons, neutrons, or any other heavy positive ions to cure cancer. Factors such as increasing incidences of cancer, rising adoption of particle therapy in clinical trials, the advent of novel technologies, and a growing number of particle therapy centers worldwide are the primarily attributing to the growth of the market. For instance, according to the National Cancer Institute, in 2018, the total number of cancer patients is accounted for 18.1 million cases and the figure is projected to rise and likely to reach 29.5 million cases. Consequentially, the rising prevalence of cancer is fueling the demand for Particle Therapy, which, in turn, accelerates the market growth across the globe. However, the growing risk of exposure to radiation and infrastructural challenges in healthcare facilities impede the growth of the market over the forecast period of 2022-2028. Also, increasing demand for particle therapy in emerging markets and growing healthcare expenditure are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Particle Therapy Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia-Pacific is the leading region across the world in terms of market share owing to the presence of the huge patient pool and growing initiatives to promote the adoption of advanced particle therapy technologies. Whereas, North America is anticipated to exhibit a substantial growth rate over the forecast period 2022-2028. Factors such as the rising preference for particle therapy owing to the various benefits offered compared to other procedures, as well as, the availability of favorable reimbursement scenarios, would create lucrative growth prospects for the Particle Therapy Market across the North American region.

Major market players included in this report are:

Varian Medical Systems, Inc.

Hitachi, Ltd.

Sumitomo Heavy Industries, Ltd.

Danfysik A/S

Hitachi, Ltd

Ion Beam Applications Sa (IBA)

Mevion Medical Systems, Inc.

Optivus Proton Therapy, Inc.

ProTom International, Inc.

Provision Healthcare, LLC

Sumitomo Heavy Industries, Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Proton Therapy

Heavy Ion Therapy

By Product & Service:

Products

Services

By Cancer Type:

Pediatric Cancer

Prostate Cancer

Lung Cancer

Breast Cancer

Head and Neck Cancer

Other Cancers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Particle Therapy Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Particle Therapy Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Particle Therapy Market, by Type, 2020-2028 (USD Million)
    • 1.2.3. Particle Therapy Market, by Product & Service, 2020-2028 (USD Million)
    • 1.2.4. Particle Therapy Market, by Cancer Type, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Particle Therapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Particle Therapy Market Dynamics

  • 3.1. Particle Therapy Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidences of cancer
      • 3.1.1.2. Rising adoption of particle therapy in clinical trials
    • 3.1.2. Market Challenges
      • 3.1.2.1. Growing risk for the exposure to radiation
      • 3.1.2.2. Infrastructural challenges in healthcare facilities
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing demand for particle therapy in emerging markets
      • 3.1.3.2. Growing healthcare expenditure

Chapter 4. Global Particle Therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Particle Therapy Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Particle Therapy Market by Type, Performance - Potential Analysis
  • 6.3. Global Particle Therapy Market Estimates & Forecasts by Type, 2018-2028 (USD Million)
  • 6.4. Particle Therapy Market, Sub Segment Analysis
    • 6.4.1. Proton Therapy
    • 6.4.2. Heavy Ion Therapy

Chapter 7. Global Particle Therapy Market, by Product & Service

  • 7.1. Market Snapshot
  • 7.2. Global Particle Therapy Market by Product & Service, Performance - Potential Analysis
  • 7.3. Global Particle Therapy Market Estimates & Forecasts by Product & Service, 2018-2028 (USD Million)
  • 7.4. Particle Therapy Market, Sub Segment Analysis
    • 7.4.1. Products
    • 7.4.2. Services

Chapter 8. Global Particle Therapy Market, by Cancer Type

  • 8.1. Market Snapshot
  • 8.2. Global Particle Therapy Market by Cancer Type, Performance - Potential Analysis
  • 8.3. Global Particle Therapy Market Estimates & Forecasts by Cancer Type, 2018-2028 (USD Million)
  • 8.4. Particle Therapy Market, Sub Segment Analysis
    • 8.4.1. Pediatric Cancer
    • 8.4.2. Prostate Cancer
    • 8.4.3. Lung Cancer
    • 8.4.4. Breast Cancer
    • 8.4.5. Head and Neck Cancer
    • 8.4.6. Other Cancers

Chapter 9. Global Particle Therapy Market, Regional Analysis

  • 9.1. Particle Therapy Market, Regional Market Snapshot
  • 9.2. North America Particle Therapy Market
    • 9.2.1. U.S. Particle Therapy Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Product & Service breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. Cancer Type breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Particle Therapy Market
  • 9.3. Europe Particle Therapy Market Snapshot
    • 9.3.1. U.K. Particle Therapy Market
    • 9.3.2. Germany Particle Therapy Market
    • 9.3.3. France Particle Therapy Market
    • 9.3.4. Spain Particle Therapy Market
    • 9.3.5. Italy Particle Therapy Market
    • 9.3.6. Rest of Europe Particle Therapy Market
  • 9.4. Asia-Pacific Particle Therapy Market Snapshot
    • 9.4.1. China Particle Therapy Market
    • 9.4.2. India Particle Therapy Market
    • 9.4.3. Japan Particle Therapy Market
    • 9.4.4. Australia Particle Therapy Market
    • 9.4.5. South Korea Particle Therapy Market
    • 9.4.6. Rest of Asia Pacific Particle Therapy Market
  • 9.5. Latin America Particle Therapy Market Snapshot
    • 9.5.1. Brazil Particle Therapy Market
    • 9.5.2. Mexico Particle Therapy Market
  • 9.6. Rest of The World Particle Therapy Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Varian Medical Systems, Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Hitachi, Ltd.
    • 10.2.3. Sumitomo Heavy Industries, Ltd.
    • 10.2.4. Danfysik A/S
    • 10.2.5. Hitachi, Ltd
    • 10.2.6. Ion Beam Applications Sa (IBA)
    • 10.2.7. Mevion Medical Systems, Inc.
    • 10.2.8. Optivus Proton Therapy, Inc.
    • 10.2.9. ProTom International, Inc.
    • 10.2.10. Provision Healthcare, LLC
    • 10.2.11. Sumitomo Heavy Industries, Ltd.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption